EX-FILING FEES 2 d616213dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form 424(b)(5)

(Form Type)

Verve Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
    

Security

Type

 

Security

Class

Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Amount

Registered(1)

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee(2)

 

Carry

  Forward  

Form

Type

 

Carry

  Forward  

File

Number

 

Carry

Forward

Initial

Effective

Date

 

Filing Fee

Previously

Paid in

Connection

with

Unsold

Securities

to be

Carried

Forward

 
Newly Registered Securities
                         
Fees to Be Paid   Equity   Common Stock, $0.001 par value per share   457(r)   14,375,000   $10.00   $143,750,000   0.0001476   $21,217.50   —     —     —     —  
                         
Fees Previously Paid   —     —     —     —     —     —     —     —     —     —     —     —  
 
Carry Forward Securities
                         
Carry Forward Securities   —     —     —     —     —     —     —     —     —     —     —     —  
                   
    Total Offering Amounts      $143,750,000     $21,217.50          
                   
    Total Fees Previously Paid          —            
                   
    Total Fee Offsets          —            
                   
    Net Fee Due                $21,217.50                

 

(1)

Assumes exercise in full of the underwriters’ option to purchase up to 1,875,000 additional shares of common stock.

(2)

In accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). This “Calculation of Filing Fee Tables” table shall be deemed to update the table in Item 14 in the registrant’s Registration Statement on Form S-3 (File No. 333-267578) in accordance with Rule 456(b) and 457(r) under the Securities Act.